Tapewire

Nasdaq · USD

BRNS

Barinthus Biotherapeutics plc.

Export transactions ↓
Tapewire entity
9597
SEC CIK
0001828185
Parsed reports
117

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 10, 2025 Filed Jun 11, 2025 17:13 UTC GrantShare Option (Right to Buy) · Derivative 20,174 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001828185-25-000041 · wk-form4_1749676396.xml · derivative · entry 1

Scheeren Joseph · CIK 0001852070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,174

Underlying: Ordinary Shares · 20,174 shares

Expires 2035-06-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) June 10, 2026 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 17:18 UTC GrantShare Option (Right to Buy) · Derivative 20,174 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001828185-25-000049 · wk-form4_1749676703.xml · derivative · entry 1

Hammacher Alex · CIK 0001851633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,174

Underlying: Ordinary Shares · 20,174 shares

Expires 2035-06-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) June 10, 2026 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 17:16 UTC GrantShare Option (Right to Buy) · Derivative 20,174 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001828185-25-000045 · wk-form4_1749676583.xml · derivative · entry 1

Morgon Pierre A. · CIK 0001851636 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,174

Underlying: Ordinary Shares · 20,174 shares

Expires 2035-06-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) June 10, 2026 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 17:17 UTC
Wright RobinDirector
GrantShare Option (Right to Buy) · Derivative 20,174 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001828185-25-000047 · wk-form4_1749676649.xml · derivative · entry 1

Wright Robin · CIK 0001851640 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,174

Underlying: Ordinary Shares · 20,174 shares

Expires 2035-06-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) June 10, 2026 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 21:15 UTC GrantShare Option (Right to Buy) · Derivative 20,174 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001828185-25-000043 · wk-form4_1749676523.xml · derivative · entry 1

Phillips Anne M. · CIK 0001627680 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,174

Underlying: Ordinary Shares · 20,174 shares

Expires 2035-06-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) June 10, 2026 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 17:10 UTC GrantShare Option (Right to Buy) · Derivative 20,174 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001828185-25-000039 · wk-form4_1749676222.xml · derivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,174

Underlying: Ordinary Shares · 20,174 shares

Expires 2035-06-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) June 10, 2026 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 16:24 UTC
Hooftman LeonChief Medical Officer
GrantShare Option (Right to Buy) · Derivative 140,000 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001828185-25-000009 · wk-form4_1738790637.xml · derivative · entry 1

Hooftman Leon · CIK 0002027157 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Ordinary Shares · 140,000 shares

Expires 2035-02-03

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 16:24 UTC
Griffiths GrahamChief Business Officer
GrantShare Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001828185-25-000010 · wk-form4_1738790649.xml · derivative · entry 1

Griffiths Graham · CIK 0001851630 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Ordinary Shares · 200,000 shares

Expires 2035-02-03

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:24 UTC
Enright WilliamDirector · Chief Executive Officer
GrantShare Option (Right to Buy) · Derivative 600,000 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001828185-25-000011 · wk-form4_1738790662.xml · derivative · entry 1

Enright William · CIK 0001705564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Ordinary Shares · 600,000 shares

Expires 2035-02-03

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:24 UTC
Brown GemmaChief Financial Officer
GrantShare Option (Right to Buy) · Derivative 160,000 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001828185-25-000012 · wk-form4_1738790675.xml · derivative · entry 1

Brown Gemma · CIK 0001947293 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Ordinary Shares · 160,000 shares

Expires 2035-02-03

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 03, 2024 Filed Jun 18, 2024 16:07 UTC
Hooftman LeonChief Medical Officer
GrantShare Option (Right to Buy) · Derivative 195,166 $0.00 Strike: $2.00 $0.00
Disclosure

SEC source: 0001104659-24-072802 · tm2417524-2_4seq1.xml · derivative · entry 1

Hooftman Leon · CIK 0002027157 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,166

Underlying: Ordinary Shares · 195,166 shares

Expires 2034-06-03

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on June 3, 2025.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 10, 2024 Filed May 14, 2024 16:21 UTC GrantShare Option (Right to Buy) · Derivative 19,516 $0.00 Strike: $2.34 $0.00
Disclosure

SEC source: 0001828185-24-000056 · wk-form4_1715718060.xml · derivative · entry 1

Scheeren Joseph · CIK 0001852070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,516

Underlying: Ordinary Shares · 19,516 shares

Expires 2034-05-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 10, 2024 Filed May 14, 2024 16:17 UTC GrantShare Option (Right to Buy) · Derivative 19,516 $0.00 Strike: $2.34 $0.00
Disclosure

SEC source: 0001828185-24-000052 · wk-form4_1715717828.xml · derivative · entry 1

Hammacher Alex · CIK 0001851633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,516

Underlying: Ordinary Shares · 19,516 shares

Expires 2034-05-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 10, 2024 Filed May 14, 2024 16:15 UTC GrantShare Option (Right to Buy) · Derivative 19,516 $0.00 Strike: $2.34 $0.00
Disclosure

SEC source: 0001828185-24-000050 · wk-form4_1715717728.xml · derivative · entry 1

Morgon Pierre A. · CIK 0001851636 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,516

Underlying: Ordinary Shares · 19,516 shares

Expires 2034-05-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 10, 2024 Filed May 14, 2024 16:13 UTC
Wright RobinDirector
GrantShare Option (Right to Buy) · Derivative 19,516 $0.00 Strike: $2.34 $0.00
Disclosure

SEC source: 0001828185-24-000048 · wk-form4_1715717606.xml · derivative · entry 1

Wright Robin · CIK 0001851640 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,516

Underlying: Ordinary Shares · 19,516 shares

Expires 2034-05-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:19 UTC GrantShare Option (Right to Buy) · Derivative 19,516 $0.00 Strike: $2.34 $0.00
Disclosure

SEC source: 0001828185-24-000054 · wk-form4_1715717940.xml · derivative · entry 1

Phillips Anne M. · CIK 0001627680 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,516

Underlying: Ordinary Shares · 19,516 shares

Expires 2034-05-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 10, 2024 Filed May 14, 2024 16:23 UTC GrantShare Option (Right to Buy) · Derivative 19,516 $0.00 Strike: $2.34 $0.00
Disclosure

SEC source: 0001828185-24-000058 · wk-form4_1715718176.xml · derivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,516

Underlying: Ordinary Shares · 19,516 shares

Expires 2034-05-10

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 08:55 UTC
Griffiths GrahamChief Business Officer
GrantShare Option (Right to Buy) · Derivative 96,500 $0.00 Strike: $3.70 $0.00
Disclosure

SEC source: 0001104659-24-001166 · tm241766-3_4seq1.xml · derivative · entry 1

Griffiths Graham · CIK 0001851630 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,500

Underlying: Ordinary Shares · 96,500 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 13:54 UTC
Enright WilliamDirector · Chief Executive Officer
GrantShare Option (Right to Buy) · Derivative 443,981 $0.00 Strike: $3.70 $0.00
Disclosure

SEC source: 0001104659-24-001165 · tm241766-2_4seq1.xml · derivative · entry 1

Enright William · CIK 0001705564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 443,981

Underlying: Ordinary Shares · 443,981 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 13:56 UTC
Pelletier NadegeChief Scientific Officer
GrantShare Option (Right to Buy) · Derivative 105,000 $0.00 Strike: $3.70 $0.00
Disclosure

SEC source: 0001104659-24-001167 · tm241766-4_4seq1.xml · derivative · entry 1

Pelletier Nadege · CIK 0001965689 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Ordinary Shares · 105,000 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 13:52 UTC
Brown GemmaChief Financial Officer
GrantShare Option (Right to Buy) · Derivative 193,000 $0.00 Strike: $3.70 $0.00
Disclosure

SEC source: 0001104659-24-001164 · tm241766-1_4seq1.xml · derivative · entry 1

Brown Gemma · CIK 0001947293 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,000

Underlying: Ordinary Shares · 193,000 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 26, 2023 Filed Jun 28, 2023 07:52 UTC PurchaseOrdinary Shares 10,000 $2.44 $24,400.00
Disclosure

SEC source: 0001104659-23-075562 · tm2319828-1_4seq1.xml · nonDerivative · entry 1

Scheeren Joseph · CIK 0001852070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,000

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 25, 2023 Filed Jun 1, 2023 16:33 UTC
Wright RobinDirector
PurchaseOrdinary Shares 13,750 $2.66 $36,612.13
Disclosure

SEC source: 0001104659-23-067081 · tm2317604-1_4seq1.xml · nonDerivative · entry 1

Wright Robin · CIK 0001851640 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,256

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.48 to $2.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
May 11, 2023 Filed May 12, 2023 16:07 UTC GrantShare Option (Right to Buy) · Derivative 19,197 $0.00 Strike: $2.27 $0.00
Disclosure

SEC source: 0001104659-23-059727 · tm2315647-5_4seq1.xml · derivative · entry 1

Scheeren Joseph · CIK 0001852070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,197

Underlying: Ordinary Shares · 19,197 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 11, 2024 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 11, 2023 Filed May 12, 2023 16:05 UTC GrantShare Option (Right to Buy) · Derivative 19,197 $0.00 Strike: $2.27 $0.00
Disclosure

SEC source: 0001104659-23-059716 · tm2315647-2_4seq1.xml · derivative · entry 1

Hammacher Alex · CIK 0001851633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,197

Underlying: Ordinary Shares · 19,197 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 11, 2024 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 11, 2023 Filed May 12, 2023 16:06 UTC GrantShare Option (Right to Buy) · Derivative 19,197 $0.00 Strike: $2.27 $0.00
Disclosure

SEC source: 0001104659-23-059722 · tm2315647-3_4seq1.xml · derivative · entry 1

Morgon Pierre A. · CIK 0001851636 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,197

Underlying: Ordinary Shares · 19,197 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 11, 2024 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 11, 2023 Filed May 12, 2023 16:07 UTC
Wright RobinDirector
GrantShare Option (Right to Buy) · Derivative 19,197 $0.00 Strike: $2.27 $0.00
Disclosure

SEC source: 0001104659-23-059729 · tm2315647-6_4seq1.xml · derivative · entry 1

Wright Robin · CIK 0001851640 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,197

Underlying: Ordinary Shares · 19,197 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 11, 2024 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 11, 2023 Filed May 12, 2023 20:07 UTC GrantShare Option (Right to Buy) · Derivative 19,197 $0.00 Strike: $2.27 $0.00
Disclosure

SEC source: 0001104659-23-059726 · tm2315647-4_4seq1.xml · derivative · entry 1

Phillips Anne M. · CIK 0001627680 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,197

Underlying: Ordinary Shares · 19,197 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 11, 2024 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 11, 2023 Filed May 12, 2023 16:05 UTC GrantShare Option (Right to Buy) · Derivative 19,197 $0.00 Strike: $2.27 $0.00
Disclosure

SEC source: 0001104659-23-059712 · tm2315647-1_4seq1.xml · derivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,197

Underlying: Ordinary Shares · 19,197 shares

Expires 2033-05-11

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on the earlier of (i) May 11, 2024 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 27, 2023 Filed Mar 29, 2023 20:41 UTC
Enright WilliamDirector · Chief Executive Officer
SaleOrdinary Shares 15,000 $2.42 $36,298.50
Disclosure

SEC source: 0001104659-23-038357 · tm2310913-1_4seq1.xml · nonDerivative · entry 1

Enright William · CIK 0001705564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 728,454

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 - $2.47. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Shares held by William J Enright TR UA Dated 03/04/2021 Enright Family 2021 Irrevocable Trust, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of the shares held by such trust for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any.

Read SEC document
February 01, 2023 Filed Feb 24, 2023 22:25 UTC
Pelletier NadegeChief Scientific Officer
GrantShare Option (Right to Buy) · Derivative 485,000 $0.00 Strike: $2.90 $0.00
Disclosure

SEC source: 0001104659-23-025391 · tm237643-6_4seq1.xml · derivative · entry 1

Pelletier Nadege · CIK 0001965689 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485,000

Underlying: Ordinary Shares · 485,000 shares

Expires 2033-02-01

F2 · derivative.exercise_date: This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 1, 2024.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 03, 2023 Filed Feb 23, 2023 16:56 UTC
Griffiths GrahamChief Business Officer
GrantShare Option (Right to Buy) · Derivative 105,000 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001104659-23-024805 · tm237643-4_4seq1.xml · derivative · entry 1

Griffiths Graham · CIK 0001851630 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Ordinary Shares · 105,000 shares

Expires 2033-01-03

F2 · derivative.exercise_date: This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 03, 2023 Filed Feb 23, 2023 16:54 UTC
Ellis ChristopherChief Operating Officer
GrantShare Option (Right to Buy) · Derivative 105,000 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001104659-23-024801 · tm237643-2_4seq1.xml · derivative · entry 1

Ellis Christopher · CIK 0001851664 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Ordinary Shares · 105,000 shares

Expires 2033-01-03

F2 · derivative.exercise_date: This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 03, 2023 Filed Feb 23, 2023 21:55 UTC
Enright WilliamDirector · Chief Executive Officer
GrantShare Option (Right to Buy) · Derivative 440,000 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001104659-23-024802 · tm237643-3_4seq1.xml · derivative · entry 1

Enright William · CIK 0001705564 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 440,000

Underlying: Ordinary Shares · 440,000 shares

Expires 2033-01-03

F2 · derivative.exercise_date: This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 03, 2023 Filed Feb 23, 2023 21:52 UTC
Brown GemmaChief Financial Officer
GrantShare Option (Right to Buy) · Derivative 33,100 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001104659-23-024799 · tm237643-1_4seq1.xml · derivative · entry 1

Brown Gemma · CIK 0001947293 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,100

Underlying: Ordinary Shares · 33,100 shares

Expires 2033-01-03

F2 · derivative.exercise_date: This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 03, 2023 Filed Mar 29, 2023 16:45 UTC
Marshall MargaretChief Medical Officer
GrantShare Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001104659-23-038365 · tm2310913-3_4seq1.xml · derivative · entry 1

Marshall Margaret · CIK 0001851634 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Ordinary Shares · 60,000 shares

Expires 2033-01-03

F2 · derivative.exercise_date: This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
January 03, 2023 Filed Mar 29, 2023 16:43 UTC
Evans Thomas GeorgeFmr Chief Scientific Officer
GrantShare Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001104659-23-038362 · tm2310913-2_4seq1.xml · derivative · entry 1

Evans Thomas George · CIK 0001851686 · Fmr Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Ordinary Shares · 125,000 shares

Expires 2033-01-03

F2 · derivative.exercise_date: This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 17:01 UTC OtherAmerican Depositary Shares 4,108,752 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-018100 · doc1.xml · nonDerivative · entry 1

M&G INVESTMENT MANAGEMENT LTD · CIK 0000922898 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see footnote

Disclosed balance after: 5,197,349

F1 · security: Each share representing one ordinary share.

F2 · ownership.nature: The reported securities are held directly by M&G ACS, advised by M&G Investment Management Limited. The reported securities may be deemed beneficially owned for the purposes of Section 13(d) of the Securities Exchange Act 1934 by M&G Investment Management Limited as investment manager to these funds. The Reporting Person disclaims beneficial ownership of the securities for purposes of Rule 16a-1(a)(2) and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 17:03 UTC OtherAmerican Depositary Shares 4,108,752 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-018101 · doc1.xml · nonDerivative · entry 1

M&G Alternatives Investment Management Ltd · CIK 0001891922 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see footnote

Disclosed balance after: 0

F1 · security: Each share representing one ordinary share.

F2 · ownership.nature: The reported securities were held directly by Prudential Credit Opportunities SCSP, advised by M&G Alternatives Investment Management Limited. The reported securities may be deemed beneficially owned for the purposes of Section 13(d) of the Securities Exchange Act 1934 by M&G Alternatives Investment Management Limited as investment manager to these funds. The Reporting Person disclaims beneficial ownership of the securities for purposes of Rule 16a-1(a)(2) and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:05 UTC
Brown GemmaChief Financial Officer
GrantShare Option (Right to Buy) · Derivative 334,000 $0.00 Strike: $3.07 $0.00
Disclosure

SEC source: 0001104659-22-103706 · tm2226822-1_4seq1.xml · derivative · entry 1

Brown Gemma · CIK 0001947293 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 334,000

Underlying: Ordinary Shares · 334,000 shares

Expires 2032-09-26

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on September 15, 2023.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
August 25, 2022 Filed Aug 26, 2022 16:27 UTC
Griffiths GrahamChief Business Officer
SaleOrdinary Shares 10,000 $7.39 $73,870.00
Disclosure

SEC source: 0001104659-22-095144 · tm2224672-2_4seq1.xml · nonDerivative · entry 1

Griffiths Graham · CIK 0001851630 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,209

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.34 - $7.44. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 25, 2022 Filed Aug 26, 2022 16:26 UTC
Ellis ChristopherChief Operating Officer
Exercise / conversionShare Option (Right to Buy) · Derivative 39,176 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001104659-22-095142 · tm2224672-1_4seq1.xml · derivative · entry 7

Ellis Christopher · CIK 0001851664 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 980

Underlying: Ordinary Shares · 39,176 shares

Expires 2028-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
August 25, 2022 Filed Aug 26, 2022 16:26 UTC
Ellis ChristopherChief Operating Officer
SaleOrdinary Shares 25,000 $7.07 $176,707.50
Disclosure

SEC source: 0001104659-22-095142 · tm2224672-1_4seq1.xml · nonDerivative · entry 5

Ellis Christopher · CIK 0001851664 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.04 - $7.12. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 25, 2022 Filed Aug 26, 2022 16:26 UTC
Ellis ChristopherChief Operating Officer
SaleOrdinary Shares 14,176 $5.69 $80,688.37
Disclosure

SEC source: 0001104659-22-095142 · tm2224672-1_4seq1.xml · nonDerivative · entry 4

Ellis Christopher · CIK 0001851664 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,075

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.46 - $5.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 25, 2022 Filed Aug 26, 2022 16:26 UTC
Ellis ChristopherChief Operating Officer
Exercise / conversionOrdinary Shares 39,176 $0.00 $15.67
Disclosure

SEC source: 0001104659-22-095142 · tm2224672-1_4seq1.xml · nonDerivative · entry 3

Ellis Christopher · CIK 0001851664 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,251

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
August 24, 2022 Filed Aug 26, 2022 16:26 UTC
Ellis ChristopherChief Operating Officer
Exercise / conversionShare Option (Right to Buy) · Derivative 450 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001104659-22-095142 · tm2224672-1_4seq1.xml · derivative · entry 6

Ellis Christopher · CIK 0001851664 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,156

Underlying: Ordinary Shares · 450 shares

Expires 2028-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
August 24, 2022 Filed Aug 26, 2022 16:26 UTC
Ellis ChristopherChief Operating Officer
SaleOrdinary Shares 450 $4.78 $2,152.22
Disclosure

SEC source: 0001104659-22-095142 · tm2224672-1_4seq1.xml · nonDerivative · entry 2

Ellis Christopher · CIK 0001851664 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 - $4.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 24, 2022 Filed Aug 26, 2022 16:26 UTC
Ellis ChristopherChief Operating Officer
Exercise / conversionOrdinary Shares 450 $0.00 $0.18
Disclosure

SEC source: 0001104659-22-095142 · tm2224672-1_4seq1.xml · nonDerivative · entry 1

Ellis Christopher · CIK 0001851664 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 525

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
August 18, 2022 Filed Aug 19, 2022 16:06 UTC
Ellis ChristopherChief Operating Officer
Exercise / conversionShare Option (Right to Buy) · Derivative 2,175 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001104659-22-092960 · tm2223471-5_4seq1.xml · derivative · entry 6

Ellis Christopher · CIK 0001851664 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,606

Underlying: Ordinary Shares · 2,175 shares

Expires 2028-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
August 18, 2022 Filed Aug 19, 2022 16:06 UTC
Ellis ChristopherChief Operating Officer
SaleOrdinary Shares 2,175 $4.84 $10,530.92
Disclosure

SEC source: 0001104659-22-092960 · tm2223471-5_4seq1.xml · nonDerivative · entry 4

Ellis Christopher · CIK 0001851664 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.18 - $4.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.